Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
625 hedge funds and large institutions have $19.2B invested in Exact Sciences in 2021 Q2 according to their latest regulatory filings, with 71 funds opening new positions, 289 increasing their positions, 143 reducing their positions, and 85 closing their positions.
102% more repeat investments, than reductions
Existing positions increased: 289 | Existing positions reduced: 143
0.44% less ownership
Funds ownership: 90.48% → 90.04% (-0.44%)
5% less capital invested
Capital invested by funds: $20.2B → $19.2B (-$965M)
3% less funds holding
Funds holding: 646 → 625 (-21)
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
16% less first-time investments, than exits
New positions opened: 71 | Existing positions closed: 85
38% less call options, than puts
Call options by funds: $189M | Put options by funds: $306M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$188M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$178M |
| 3 |
Sumitomo Mitsui Trust Group
Minato-Ku, Tokyo,
Japan
|
+$127M |
| 4 |
NAMA
Nikko Asset Management Americas
New York
|
+$125M |
| 5 |
State Street
Boston,
Massachusetts
|
+$63.5M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
-$337M |
| 2 |
VOYA Investment Management
Atlanta,
Georgia
|
-$174M |
| 3 |
N
Natixis
Paris,
France
|
-$83.1M |
| 4 |
Victory Capital Management
San Antonio,
Texas
|
-$57.9M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$47.7M |
EXAS Hedge Fund Activity: Q2 2021 in Review
625 of the 5,768 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q2 2021, worth a combined $19.2B — down 4.8% from $20.2B a quarter earlier.
Sellers outnumbered buyers: 85 funds closed out of EXAS and 71 opened new positions — a net loss of 14 holders — while 143 trimmed existing stakes and 289 added.
The largest buyer was ARK Investment Management, adding an estimated $188M. The largest seller was Capital World Investors, cutting an estimated $337M.
- 625 institutional investors held Exact Sciences (EXAS) as of Q2 2021, down from 646 in Q1 2021.
- Funds reported $19.2B of Exact Sciences stock for Q2 2021, down 4.8% quarter-over-quarter.
- 71 funds opened new Exact Sciences positions in Q2 2021 and 85 closed out, a net change of -14 holders.
- The largest Exact Sciences buyer in Q2 2021 was ARK Investment Management, an estimated $188M added.
- The largest Exact Sciences seller in Q2 2021 was Capital World Investors, an estimated $337M sold.
Based on aggregated 13F filings for Q2 2021.